February 02, 2023

Pliant Therapeutics

Pliant Therapeutics Announces FDA Clearance of Investigational New Drug Application for PLN-101095, A Novel Integrin Inhibitor for the Treatment of Solid Tumors

February 02, 2023

Magenta Therapeutics

Magenta Therapeutics to Explore Strategic Alternatives

January 31, 2023

Casma Therapeutics

Casma Therapeutics Announces CEO Transition

January 27, 2023

Pliant Therapeutics

Pliant Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

January 25, 2023

Tango Therapeutics

Tango Therapeutics Announces FDA Clearance Of Investigational New Drug Application For TNG462; Provides Additional Business Updates

Load More

Sign up for weekly portfolio news.